Related Experiment Video
Updated: Jul 31, 2026

08:34
Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
Adrenal glucocorticoids regulate adipsin gene expression in genetically obese mice
B M Spiegelman1, B Lowell, A Napolitano
1Dana-Farber Cancer Institute, Boston, Massachusetts 02115.
The Journal of Biological Chemistry
|January 25, 1989
Summary
Adipsin levels are reduced in obesity models. Glucocorticoids, regulated by the adrenal gland, significantly lower adipsin expression, suggesting a role in obesity-related adipsin suppression.
Area of Science:
- Endocrinology
- Obesity Research
- Molecular Biology
Background:
- Adipsin expression is significantly reduced in various mouse models of obesity, including genetic (db/db, ob/ob) and chemically induced forms.
- The adipsin structural gene is located on chromosome 10, distinct from known mouse obesity genes.
Purpose of the Study:
- To investigate the role of the adrenal gland and glucocorticoids in the regulation of adipsin expression in obesity.
- To determine if glucocorticoids directly influence adipsin levels in vivo.
Main Methods:
- Adrenalectomy in ob/ob mice to assess adipsin protein and mRNA levels.
- Administration of corticosterone to both obese and lean mice to evaluate its effect on adipsin expression.
- Quantitative analysis of adipsin mRNA and protein levels.
Main Results:
- Adrenalectomy in ob/ob mice increased adipsin protein and mRNA, but not to lean control levels.
- Corticosterone administration blocked the effects of adrenalectomy and suppressed adipsin in lean mice.
- Glucocorticoids were shown to regulate adipsin expression in vivo, with a more severe suppression observed in obese mice.
Conclusions:
- The hyperglucocorticoid state in certain obese models significantly contributes to the lowering of adipsin mRNA and protein levels.
- Glucocorticoids play a key role in regulating adipsin expression.
- Additional unknown neuroendocrine factors may also suppress adipsin in obesity.
Related Concept Videos
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...

